The Insurance Helpline
Totally Insured Group // 0800 377 7763

Ever smaller and easier to use insulin inhalers are revolutionising the lifestyle and health of diabetes sufferers.

Pfizer is now developing next generation inhalers, new and improved versions of what is a breakthrough treatment for Type 1 and Type 2 diabetes.

This is a follow up to Pfizer’s Exubera, which was launched last year.

Inhaled insulin is a better way of controlling blood sugar levels and releases people with diabetes from a lifetime of injections.

A one per cent reduction in a diabetic’s A1C blood sugar level can reduce the risk of eye, kidney, nerve and heart damage by up to 43 per cent, according to a study published in the British Medical Journal.

Pfizer says: "Exubera [is] the world’s first form of inhaled insulin for the treatment of Type 1 and Type 2 diabetes, which offers life-altering treatment options to patients.

"Although this is a breakthrough in diabetes treatment and delivery technology, we are now working on the next generation of inhaler to make the management of diabetes even easier."

Eli Lilly is also working on an even smaller and easier to use inhaled insulin device, based on air technology, due to be released in 2009.

This entry was posted on Monday, October 1st, 2007 at 3:07 pm and is filed under Uncategorized.